Zacks Research Issues Negative Outlook for Chemours Earnings

The Chemours Company (NYSE:CC) – Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Chemours in a report issued on Monday, May 18th. Zacks Research analyst Team now anticipates that the specialty chemicals company will post earnings per share of $0.41 for the quarter, down from their prior estimate of $0.42. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Chemours’ current full-year earnings is $1.31 per share. Zacks Research also issued estimates for Chemours’ Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.90 EPS, Q1 2027 earnings at $0.41 EPS, Q2 2027 earnings at $0.47 EPS, Q3 2027 earnings at $0.57 EPS, Q4 2027 earnings at $0.50 EPS, FY2027 earnings at $1.95 EPS, Q1 2028 earnings at $0.55 EPS and FY2028 earnings at $2.36 EPS.

A number of other equities research analysts also recently weighed in on CC. UBS Group raised their price objective on Chemours from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a research report on Monday, April 20th. BMO Capital Markets dropped their price objective on Chemours from $20.00 to $19.00 and set an “outperform” rating on the stock in a research report on Monday, February 23rd. Royal Bank Of Canada raised their price objective on Chemours from $26.00 to $29.00 and gave the company an “outperform” rating in a research report on Monday, May 11th. Finally, JPMorgan Chase & Co. raised their price objective on Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a research report on Monday, February 23rd. Six equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Chemours currently has a consensus rating of “Hold” and a consensus target price of $23.09.

Chemours Trading Down 5.2%

CC opened at $21.75 on Wednesday. The stock’s fifty day moving average is $22.19 and its two-hundred day moving average is $17.19. The company has a market capitalization of $3.27 billion, a P/E ratio of -8.24 and a beta of 1.47. Chemours has a 52 week low of $9.13 and a 52 week high of $28.67. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98.

Chemours (NYSE:CC) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.40 billion. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.Chemours’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.13 EPS.

Chemours Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a yield of 1.6%. Chemours’s payout ratio is currently -13.26%.

Institutional Trading of Chemours

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Y Intercept Hong Kong Ltd acquired a new position in shares of Chemours in the 3rd quarter valued at about $2,124,000. WINTON GROUP Ltd lifted its holdings in shares of Chemours by 103.5% in the 3rd quarter. WINTON GROUP Ltd now owns 114,100 shares of the specialty chemicals company’s stock valued at $1,807,000 after buying an additional 58,039 shares during the period. SG Americas Securities LLC lifted its holdings in shares of Chemours by 478.4% in the 4th quarter. SG Americas Securities LLC now owns 236,236 shares of the specialty chemicals company’s stock valued at $2,785,000 after buying an additional 195,393 shares during the period. Hudson Bay Capital Management LP acquired a new position in shares of Chemours in the 3rd quarter valued at about $1,925,000. Finally, Wolf Hill Capital Management LP acquired a new position in shares of Chemours in the 3rd quarter valued at about $17,025,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

More Chemours News

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours saw unusually heavy options activity, with traders buying 33,698 call contracts versus a normal volume of about 6,050, suggesting some investors are positioning for a rebound or upside move. Chemours stock page
• Neutral Sentiment: Zacks Research maintained a Hold rating while leaving its broader outlook mixed, including higher estimates for some later periods such as Q4 2027, Q3 2027, and FY2028 compared with prior views. Chemours stock page
• Negative Sentiment: Zacks Research cut several near- and medium-term earnings forecasts for Chemours, including FY2026 EPS to $0.90 from $1.06, Q4 2026 to $0.12 from $0.13, Q1 2027 to $0.41 from $0.45, Q2 2027 to $0.47 from $0.53, and Q1 2028 to $0.55 from $0.59, signaling pressure on expected profitability. Chemours stock page
• Negative Sentiment: The analyst also trimmed FY2027 and FY2028 earnings estimates, which may reinforce concerns that Chemours’ earnings recovery could be slower than previously expected. Chemours stock page

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.